Evidence map›Paper›PMID 24649013›Full record

ArticleBiomedical reports2013

Homology modeling and molecular dynamics studies of Wilms' tumor gene 1 frameshift mutations in exon 7.

Shaoyan Hu, Ying Wang, Shuiyan Wu, Mingying Zhang, Jian Pan, Hongjie Shen, Xiaofei Qi, Jiannong Cen, Zixing Chen, Bairong Shen and 1 more

Open access · bronzeAbstract read
In one paragraph

Article in Biomedical reports, 2013. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact, top 89% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed, 1 citations in OpenAlex.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 2 institutions in 1 country.

Shaoyan HuDepartment of Hematology and Oncology, The Children's Hospital of Soochow University, Suzhou, Jiangsu 215003, P.R. China.
Ying WangDepartment of Hematology and Oncology, The Children's Hospital of Soochow University, Suzhou, Jiangsu 215003, P.R. China.
Shuiyan WuDepartment of Hematology and Oncology, The Children's Hospital of Soochow University, Suzhou, Jiangsu 215003, P.R. China.
Mingying ZhangDepartment of Hematology and Oncology, The Children's Hospital of Soochow University, Suzhou, Jiangsu 215003, P.R. China.
Jian PanDepartment of Hematology and Oncology, The Children's Hospital of Soochow University, Suzhou, Jiangsu 215003, P.R. China.
Hongjie ShenJiangsu Institute of Hematology, The First Affiliated Hospital of Soochow University, Suzhou, Jiangsu, P.R. China.
Xiaofei QiJiangsu Institute of Hematology, The First Affiliated Hospital of Soochow University, Suzhou, Jiangsu, P.R. China.
Jiannong CenJiangsu Institute of Hematology, The First Affiliated Hospital of Soochow University, Suzhou, Jiangsu, P.R. China.
Zixing ChenJiangsu Institute of Hematology, The First Affiliated Hospital of Soochow University, Suzhou, Jiangsu, P.R. China.
Bairong ShenCenter for Systems Biology, Soochow University, Suzhou, Jiangsu, P.R. China.
Ruihua ChenInstitute of Clinical Immunology, The First Affiliated Hospital of Soochow University, Suzhou, Jiangsu 215006, P.R. China.
Soochow University · CNFirst Affiliated Hospital of Soochow University · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

As a transcription factor, the Wilms' tumor 1 (WT1) gene plays an important role in leukemogenesis. The impact of WT1 gene mutations has been reported in acute myeloid leukemia (AML). However, the number of available studies on the spatial configuration changes following WT1 mutation is limited. In this study, we sequenced the mutation in exon 7 of the WT1 gene in 60 children with newly diagnosed AML and the spatial configuration of WT1 with frameshift mutations in exon 7 was evaluated using the software for homology modeling and optimization of molecular dynamics. Three cases with frameshift mutations in exon 7 were identified (3/60; mutation rate, 5%). One case had a mutation that had been previously described, whereas the remaining two mutations were first described in our study. Of the three cases, one case presented with antecedent myelodysplastic syndrome (MDS) and the remaining two cases exhibited primary resistance to induction chemotherapy. The spatial configuration analysis demonstrated that the three mutations affected the spatial structure of exon 7 and even affected exon 8 compared to its wild-type. This study demonstrated that the frameshift mutation in exon 7 of the WT1 gene is a poor prognostic factor for children with AML, partly through the spatial configuration changes following frameshift mutations of WT1, which highlights the structure-based function analysis and may facilitate the elucidation of the pathogenesis underlying WT1 gene mutations.

Indexed as

acute myeloid leukemiachildrenframeshift mutationmyelodysplastic syndromeresistance to chemotherapyWilms' tumor gene 1

Identifiers

PMID24649013
PMCPMC3917735
OpenAlexW2142274782

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.